WallStSmart

Cigna Corp (CI)vsCentene Corp (CNC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cigna Corp generates 56% more annual revenue ($274.90B vs $176.15B). CI leads profitability with a 2.2% profit margin vs -3.8%. CI appears more attractively valued with a PEG of 0.76. CNC earns a higher WallStSmart Score of 65/100 (B-).

CI

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 5.5Value: 7.3Quality: 4.8
Piotroski: 2/9

CNC

Strong Buy

65

out of 100

Grade: B-

Growth: 8.0Profit: 4.0Value: 6.7Quality: 5.8
Piotroski: 4/9Altman Z: 2.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CISignificantly Overvalued (-74.3%)

Margin of Safety

-74.3%

Fair Value

$150.82

Current Price

$262.84

$112.02 premium

UndervaluedFair: $150.82Overvalued

Intrinsic value data unavailable for CNC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CI5 strengths · Avg: 8.6/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Market CapQuality
$70.21B9/10

Large-cap with strong market position

PEG RatioValuation
0.768/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$5.83B8/10

Generating 5.8B in free cash flow

CNC4 strengths · Avg: 8.5/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.778/10

Growing faster than its price suggests

Revenue GrowthGrowth
23.2%8/10

Revenue surging 23.2% year-over-year

EPS GrowthGrowth
21.8%8/10

Earnings expanding 21.8% YoY

Areas to Watch

CI4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.2%3/10

2.2% margin — thin

Operating MarginProfitability
3.5%3/10

Operating margin of 3.5%

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-9.3%2/10

Earnings declined 9.3%

CNC3 concerns · Avg: 1.3/10
Return on EquityProfitability
-28.7%2/10

ROE of -28.7% — below average capital efficiency

Profit MarginProfitability
-3.8%1/10

Currently unprofitable

Operating MarginProfitability
-1.9%1/10

Operating margin of -1.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : CI

The strongest argument for CI centers on P/E Ratio, Market Cap, PEG Ratio. Revenue growth of 10.4% demonstrates continued momentum. PEG of 0.76 suggests the stock is reasonably priced for its growth.

Bull Case : CNC

The strongest argument for CNC centers on Price/Book, PEG Ratio, Revenue Growth. Revenue growth of 23.2% demonstrates continued momentum. PEG of 0.77 suggests the stock is reasonably priced for its growth.

Bear Case : CI

The primary concerns for CI are Profit Margin, Operating Margin, Piotroski F-Score. Thin 2.2% margins leave little buffer for downturns.

Bear Case : CNC

The primary concerns for CNC are Return on Equity, Profit Margin, Operating Margin.

Key Dynamics to Monitor

CI profiles as a value stock while CNC is a growth play — different risk/reward profiles.

CNC carries more volatility with a beta of 0.46 — expect wider price swings.

CNC is growing revenue faster at 23.2% — sustainability is the question.

CI generates stronger free cash flow (5.8B), providing more financial flexibility.

Bottom Line

CNC scores higher overall (65/100 vs 63/100) and 23.2% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cigna Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).

Visit Website →

Centene Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.

Want to dig deeper into these stocks?